Recap: Autolus Therapeutics Q2 Earnings

Autolus Therapeutics AUTL reported its Q2 earnings results on Thursday, August 4, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Autolus Therapeutics beat estimated earnings by 9.8%, reporting an EPS of $-0.46 versus an estimate of $-0.51.

Revenue was down $1.65 million from the same period last year.

Last quarter the company beat on EPS by $0.1 which was followed by a 12.88% drop in the share price the next day.

Here's a look at Autolus Therapeutics's past performance:

Quarter	Q1 2022	Q4 2021	Q3 2021	Q2 2021
EPS Estimate	-0.51	-0.51	-0.51	-0.50
EPS Actual	-0.41	-0.51	-0.47	-0.47
Revenue Estimate	250K	250K	250K	190K
Revenue Actual	166K	180K	236K	1.65M

To track all earnings releases for Autolus Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar